Edition:
United States

Teleflex Inc (TFX.N)

TFX.N on New York Stock Exchange

211.77USD
21 Aug 2017
Change (% chg)

-- (--)
Prev Close
$211.77
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
71,885
52-wk High
$217.97
52-wk Low
$136.64

TFX.N

Chart for TFX.N

About

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments:... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $9,537.57
Shares Outstanding(Mil.): 45.04
Dividend: 0.34
Yield (%): 0.64

Financials

  TFX.N Industry Sector
P/E (TTM): 40.52 29.96 32.62
EPS (TTM): 5.23 -- --
ROI: 5.79 13.85 14.94
ROE: 10.98 16.65 16.18

BRIEF-Arrow Seldinger Arterial Catheterization Device receives FDA market clearance - Teleflex Inc

* Teleflex Inc says that its Arrow Seldinger Arterial Catheterization Device received market clearance from U.S. Food And Drug Administration

Jul 24 2017

BRIEF-Teleflex commences phase I clinical study of RePlas freeze-dried plasma

* Teleflex (TFX) announces commencement of phase i clinical study (FDP-1) of RePlas™ freeze-dried plasma

May 15 2017

BRIEF-Teleflex receives FDA 510(k) clearance for Arrow AC3 Optimustm Intra-Aortic Balloon Pump

* Teleflex receives fda 510(k) clearance for the arrow® ac3 optimustm intra-aortic balloon pump (iabp)

May 02 2017

BRIEF-Pyng receives securityholder approval for acquisition by Teleflex

* Pyng receives securityholder approval for acquisition by Teleflex Source text for Eikon: Further company coverage:

Mar 27 2017

BRIEF-Teleflex announces U.S. commercial launch of spectre guidewire

* Teleflex Inc says has announced 510(k) clearance by Food and Drug Administration and U.S. commercial launch of spectre guidewire Source text for Eikon: Further company coverage:

Mar 14 2017

BRIEF-Teleflex posts Q4 EPS of $1.29 from continuing operations

* Teleflex reports fourth quarter and full year 2016 results; provides 2017 guidance

Feb 23 2017

BRIEF-Teleflex announces 510(k) clearance and US launch of trapliner catheter

* Teleflex (TFX) announces 510(k) clearance and US launch of trapliner catheter Source text for Eikon: Further company coverage:

Feb 22 2017

Competitors

  Price Chg
C R Bard Inc (BCR.N) $319.42 --
Medtronic PLC (MDT.N) $83.52 --
Becton Dickinson and Co (BDX.N) $199.17 --

Earnings vs. Estimates